Patents by Inventor Mark Andrew Seefeld

Mark Andrew Seefeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibacterial agents
    Patent number: 7605169
    Abstract: Napthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: October 20, 2009
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7592334
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20090181955
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: March 26, 2009
    Publication date: July 16, 2009
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7511035
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: March 31, 2009
    Assignee: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Inhibitors of Akt Activity
    Publication number: 20080318947
    Abstract: Invented are novel 1H-imidazo[4,5-c]pyridin-2-yl compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: April 20, 2006
    Publication date: December 25, 2008
    Inventors: Dirk A. Heerding, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20080194547
    Abstract: Naphthalene, quinoline, quinoaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 8, 2005
    Publication date: August 14, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20080146551
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: June 19, 2008
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20080139540
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: June 12, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Antibacterial Agents
    Publication number: 20080139539
    Abstract: Naphthyridine and quinoline derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: June 12, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Henry Miller, Meagan B. Rouse, Mark Andrew Seefeld
  • Aminopiperidine derivatives
    Patent number: 7312212
    Abstract: Piperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Grant
    Filed: January 27, 2003
    Date of Patent: December 25, 2007
    Assignee: Glaxo Group Limited
    Inventors: Robert A Daines, William Henry Miller, Neil David Pearson, Israil Pendrak, Mark Andrew Seefeld
  • Antibacterial agents
    Patent number: 7232832
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: June 19, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Jeffrey Michael Axten, William Henry Miller, Mark Andrew Seefeld
  • Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
    Patent number: 7109213
    Abstract: Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Grant
    Filed: January 27, 2003
    Date of Patent: September 19, 2006
    Assignee: Glaxo Group Limited
    Inventors: Robert A Daines, William Henry Miller, Neil David Pearson, Israil Pendrak, Mark Andrew Seefeld